Promising Researcher Scholarship & Mentorship
Master the Art of Medical Research in Oncology with PRISM 2026
A research and mentorship program on Multiple Myeloma and Lung Cancer for the brightest young doctors in India.
What is
PRISM
?
👉
PRISM (Promising Researcher Scholarship & Mentorship) nurtures research skills in young doctors and post-grad students in India
👉
It offers a national poster contest in the Multiple Myeloma and Lung Cancer therapy areas, and you can now register your interest and submit proposals in either therapy area
👉
Get mentored by IIPHG (Indian Institute of Public Health, Gandhinagar) experts and specialists, with a chance to win a scholarship and top researcher recognition
👉
Learn how to work with Real World Data (RWD) and Real World Evidence (RWE). Build understanding of how Patient Reported Outcomes (PROs) are shaping new evidence
Benefits To Participants
PRISM is your path to mastering research and building a publication portfolio
View hospital Real World Data through a new lens, turning it into Real World Evidence to improve healthcare in India
Learn statistical tools, cohort studies, & case series while preparing for publication with expert mentorship
Gain exposure and mentorship through the poster contest, presenting to a panel of experts
Top 5 submissions in each therapy area get mentorship and a chance to present on a national stage
The Top two Posters will receive a scholarship of Rs. 50,000 (first place) and Rs. 25,000 (second place) to publish in a reputed journal
How It Works?
1
Show Interest
Enroll in the PRISM 2026 by 29th March
2
Submit Proposal
Pick a problem in Multiple Myeloma or Lung Cancer therapy areas or propose your own. Submit your proposal by 30th April
3
Get Mentorship
Select 5 participants/teams in each therapy area get expert feedback to refine their research from March - May 2026
4
Present Poster
Virtual Poster Presentation and Awards in June 2026
3
Get Mentorship
Select 5 participants/teams in each therapy area get expert feedback to refine their research from March - May 2026
Key Dates to Remember
PRISM
2026
Shortlisted Proposals for Multiple Myeloma and Lung Cancer
We would like to say a huge thank you to everyone who participated in the PRISM program last year!
Dr. B S Srinivas
Final Year MBBS @ MVJ Medical College and Research Hospital (MVJMC&RH), Bangalore
Real-world barriers and utilization of comprehensive molecular testing (EGFR, ALK, ROS1, PDL1 and ctDNA) in advanced NSCLC at tertiary cancer centres in Bengaluru.
Dr. Nithiya Piriya
Senior Resident - Medical Oncology @ Coimbatore Medical College,
Molecular Testing Patterns and Treatment Gaps in Non-Small Cell Lung Cancer (NSCLC) in Resource-Limited Settings: A Real-World Study.
Dr. Satyam Patel
Consultant Medical Oncologist @ HCG Cancer Centre, Ahmedabad
Real-World Impact of Molecular Testing, Treatment Patterns, and Access to Targeted Therapy in Advanced NSCLC: An Indian Experience.
Dr. Shreya Dhingra
Radiation Oncologist and Senior Resident @ Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
Lack of Standardised Therapy After Third-Generation ALK TKI Progression in ALK-Rearranged Non-Small Cell Lung Cancer: Characterising Resistance Mechanisms and Establishing Evidence-Based Treatment Pathways.
Dr. Thahaseen Basheer
PG Registrar - Internal Medicine @ Aster Medicity,
INDIA-NSLS — Development and Prospective Validation of the Indian Non-Smoker Lung Screening Score: A Novel 9-Domain Risk Stratification Tool for Lung Cancer Detection in Never-Smokers at a Private Quaternary Centre in India.
Dr. Aswini Balagangatharan
MBBS, Academic medical resident @ Apollo Greams Main Hospital, Chennai
Prevalence and accessibility testing of high-risk cytogenetic abnormalities in Multiple Myeloma in a real-world Indian setting.
Dr. Bijita Dutta
DM Clinical Hematology, Assistant Professor @ ESI PGIMSR, ESIC MCH, Joka, Kolkata
Optimizing the Prevention of Skeletal-Related Events in Multiple Myeloma: A Retrospective Study on Use of Osteoclast Inhibitors.
Dr. Farzana Siddiqui
MD Pathology, Assistant Professor @ Balvir Singh Tomar Institute of Medical Science and Research, Jaipur
Clinicopathological Correlation of Bone Marrow Morphology, Serum Protein Electrophoresis and Biochemical Parameters in Patients with Multiple Myeloma: A Retrospective Case Series.
Dr. Iffat Jamal
MD Pathology, Additional Professor @ Indira Gandhi Institute Of Medical Sciences (IGIMS), Patna
Effects of Bortezomib-based regimens on hematological and biochemical parameters including electrophoretic patterns in patients of Multiple myeloma: a single center experience from Eastern India.
Dr. Nithiya Piriya
Senior Resident - Medical Oncology @ Coimbatore Medical College,
Real-World Outcomes of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Regimen in Multiple Myeloma in Resource-Limited Settings: A Retrospective Cohort Study.
Meet the Mentors
Dr. Biju George, MD Medicine, DM Clinical Hematology
Professor of Clinical Hematology, CMC Vellore National leader in stem cell transplantation Pioneer of haplo-identical transplants (PTCy) in India Developed nationally adopted aplastic anaemia conditioning protocols
Dr. Shalu R Chaudhary
MBBS, MD Community Medicine, CCEBDM, Executive Diploma PHN, PhD Scholar Faculty at Indian Institute of Public Health Gandhinagar. Leads Independent Verification Agency for SRESTHA Gujarat (World Bank Project). Public Health Nutrition, Epidemiology and Health systems and policy expert. PI/Co-PI for several research projects
Dr Vaibhav Choudhary, DM Medical Oncology, MRCP
Director Medical and Precision Oncology, Nanavati Max Super Speciality Hospital Certified in Genetics & Precision Oncology, Cancer Immunotherapy & Gene Therapy, Harvard Medical School. Specialty Certificate in Medical Oncology (SCE), Royal College of Physicians.
Dr Akhil Kapoor, DM Medical Oncology
Professor and Head Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi Specialising in lung, head neck, breast, and genitourinary cancers Recognised for leading research in immunotherapy, metronomic therapy, cancer genetics and geriatric oncology
Dr. Medha Wadhwa
Assistant Professor, Indian Institute of Public Health Gandhinagar (IIPHG), India BDS, MBA (Healthcare), UGCNET, PG Diploma in Research Methodology, PhD in Healthcare Management
Dr. Biju George, MD Medicine, DM Clinical Hematology
Professor of Clinical Hematology, CMC Vellore National leader in stem cell transplantation Pioneer of haplo-identical transplants (PTCy) in India Developed nationally adopted aplastic anaemia conditioning protocols
Dr. Shalu R Chaudhary
MBBS, MD Community Medicine, CCEBDM, Executive Diploma PHN, PhD Scholar Faculty at Indian Institute of Public Health Gandhinagar. Leads Independent Verification Agency for SRESTHA Gujarat (World Bank Project). Public Health Nutrition, Epidemiology and Health systems and policy expert. PI/Co-PI for several research projects
Dr Vaibhav Choudhary, DM Medical Oncology, MRCP
Director Medical and Precision Oncology, Nanavati Max Super Speciality Hospital Certified in Genetics & Precision Oncology, Cancer Immunotherapy & Gene Therapy, Harvard Medical School. Specialty Certificate in Medical Oncology (SCE), Royal College of Physicians.
Dr Akhil Kapoor, DM Medical Oncology
Professor and Head Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi Specialising in lung, head neck, breast, and genitourinary cancers Recognised for leading research in immunotherapy, metronomic therapy, cancer genetics and geriatric oncology
Dr. Medha Wadhwa
Assistant Professor, Indian Institute of Public Health Gandhinagar (IIPHG), India BDS, MBA (Healthcare), UGCNET, PG Diploma in Research Methodology, PhD in Healthcare Management
PRISM is an initiative to foster a research mindset among young doctors in India and generate high-quality local evidence
Institutional Partner
Implementation Partner
Supported through an educational grant from
Frequently Asked Questions
Contact Us
support@medflix.app
+91 9023-729662
Terms
Privacy
FAQs
© 2026 Plexus Professionals Network Pvt Ltd.